RecruitingNot ApplicableNCT07362056

Implementing Suicide Prevention Into Primary Care in Nepal

Integrating a Suicide Prevention Package of Strategies Into Decentralized Primary Health Care Systems: an Implementation Pilot Study in Rural Nepal


Sponsor

Yale University

Enrollment

147 participants

Start Date

Nov 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Suicide remains a major contributor to global mortality, with particularly high and persistent rates in low-resourced settings such as South Asia. In Nepal, ongoing integration of mental health services into primary care provides a critical opportunity to strengthen suicide risk assessment and management. Despite the scale-up of mhGAP training for primary care providers (PCPs), gaps remain in the systematic detection, referral, and follow-up of individuals at risk for suicide. There is an urgent need to enhance mhGAP implementation with strategies that address provider workload, stigma, and inequities within the health workforce. Using experience-based co-design principles and RE-AIM this study will assess the feasibility and acceptability of integrating an implementation strategy package to optimize mhGAP suicide prevention delivery in Nepal's decentralized primary healthcare system. This clinical trial leverages deep collaboration with a community advisory board of individuals with lived experience of suicide throughout the trials' design, delivery and analysis. This R34 will generate critical preliminary evidence on the feasibility, acceptability, and implementation of an integrated suicide prevention package within government primary care facilities in Nepal. The findings will inform the design and parameters of a future fully powered effectiveness trial, while aligning with Nepal's national suicide prevention strategy and advancing WHO and NIMH global mental health priorities.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to build and test a suicide prevention program within primary care clinics in Nepal, training healthcare workers to identify and support patients at risk of suicide using a standardized mental health tool. **You may be eligible if you are a healthcare provider:** - You are a licensed health worker (prescriber) employed at a government health facility in Bagmati Province, Nepal - You are between 21 and 65 years old - You speak Nepali and are actively providing patient care - You plan to remain in the study area for at least one year **You may be eligible if you are a patient:** - You live in the study area and are receiving care at a participating clinic - You have been assessed as having any level of suicide risk using the mhGAP 2.0 screening tool - You speak Nepali **You may NOT be eligible if...** - As a provider: you do not have proper government credentials, or you plan to leave the study area within a year - As a patient: you need immediate hospitalization, or you cannot give consent due to diminished capacity Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSuicide Prevention Package (PSuPP)

Implementation package to optimize mhGAP siucide prevention delivery which includes: \[assessment optimization\] systematic assessment training using systematized screening questions, an embedded decision-support tool, \[risk management optimization\] culturally adapted safety planning, and \[follow up care optimization\] a collaborative care protocol with CHWs to support patient follow-up uptake and continued care.


Locations(1)

Primary care facilities

Dolakhā, Nepal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07362056


Related Trials